.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Evermore Cannabis Company is stocked at 105 licensed dispensaries across Maryland, with the deepest coverage in Baltimore, Rockville, Silver Spring, Annapolis, and Columbia. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Evermore Cannabis Company’s mix tilted further toward Flower at 60.9% share, with Flower sales up 26.7% year over year and 18.0% month over month, while the brand’s average price fell 8.0% YoY to $28.77, indicating volume-led gains. Pre-Roll held 15.8% share with a contrasting -7.5% YoY but a 43.7% MoM surge, suggesting recent list expansion or promotional pull that did not exist a year prior; meanwhile, Vapor Pens slipped with -30.4% YoY and -1.7% MoM on an 8.1% share, and Concentrates posted a modest 2.2% YoY with -1.2% MoM at 9.5% share. Edible contributed 4.8% share with 14.7% YoY but -5.2% MoM, and Capsules remained niche at 0.9% share with -33.2% YoY and a 5.0% MoM uptick. With Flower ranked 6 in Maryland and category gains outpacing the brand-level 9.2% YoY sales growth, the pattern implies Evermore is leaning into higher-velocity inhalables while managing price elasticity to drive mix-led volume.
The combination of a Flower-heavy base and divergent Pre-Roll momentum (-7.5% YoY versus +43.7% MoM) implies Evermore is using near-term pricing or assortment tactics to convert quick wins without fixing longer-cycle demand, while the -30.4% YoY in Vapor Pens alongside only -1.7% MoM points to stabilization but not recovery. With Concentrates at 9.5% share growing 2.2% YoY and edging down 1.2% MoM, and Edible at 4.8% share growing 14.7% YoY yet contracting 5.2% MoM, the brand’s breadth cushions volatility but concentrates growth in two pillars—Flower and Pre-Roll—where execution shifts move share fastest. Taken together with a 6th-place Flower rank in Maryland and an 8.0% YoY price decline, the positioning implies Evermore is prioritizing accessible price points and inhalable depth to gain throughput, while underweight performance in Vapor Pens caps premium-mix upside.
Competitive Landscape
Evermore Cannabis Company sits at rank #6 in MD Flower for September 2026, improving 1 position from #7 year over year, while also moving up 1 spot from #7 in June 2026; by contrast, Strane advanced from #10 to #5 year over year and District Cannabis slid from #2 to #4 with a 29.36% YoY sales decline, indicating competitive churn above and around Evermore. Evermore’s current #6 is one notch off its peak #5 in December 2025, whereas RYTHM holds #3 with a 3.59% YoY sales contraction and Fade Co. is #2 after rising from #3 alongside 8.93% YoY growth, implying Evermore’s modest rank lift masks rising pressure from faster climbers and that maintaining share will likely require outpacing mid-tier movers rather than chasing the entrenched #1 SunMed.
Notable Products
Red Zushi (3.5g) delivered the standout move in September 2026 with an 85.6% month-over-month jump and a climb to rank 1, while Rainbow Push Pop #4 (3.5g) also crossed the +50% threshold at +54.0% to hold rank 7. Swampwater Fumez (3.5g) rose 50.7% to rank 6, and Sour Peel (3.5g) and Funky Guava (3.5g) advanced 24.8% and 29.9% to ranks 4 and 5 respectively, concentrating five of the top ten in Flower. With no top-10 SKU posting a double-digit decline and Pre-Roll entries limited to ranks 2, 3, and 9, the mix tilts toward higher-velocity Flower as the volume engine. The pattern implies Evermore Cannabis Company is leaning into premium eighths as the core growth driver, using a few pre-roll formats for reach while prioritizing Flower for share expansion.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
